Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

3-D irradiation of brain cancer in children spares IQ, memory, other cognitive functions

06.08.2004


Encouraging results of Phase II conformal radiation trial for ependymoma could resolve the dilemma on whether to withhold therapeutic radiation from children to preserve their cognitive development

A radiation therapy technique that kills brain tumors in children while sparing normal tissue allows young patients to enjoy normal development of memory, reasoning, problem-solving and other cognitive functions, according to investigators at St. Jude Children’s Research Hospital. The results of a Phase II clinical trial of this technique, called conformal radiation therapy (CRT), hold promise for sparing cognitive development even in children younger than three years.

This research is published in the August issue of the Journal of Clinical Oncology. The St. Jude study found that about 75 percent of the children treated for ependymoma with CRT did not experience progression of their cancer after three years, and their cognitive development was not significantly impaired by radiation therapy.



Ependymoma is a malignant brain tumor that occurs predominately in children. About 150 cases occur in the United States each year among people younger than 14 years.

The study’s findings could offer an answer to a long-standing dilemma facing physicians treating children who have brain tumors, according to Thomas Merchant, D.O., Ph.D., chief of Radiation Oncology at St. Jude. Following surgery to remove as much of the tumor as possible, radiation treatment is more effective than chemotherapy at eradicating the remaining cancer. However, despite its lower rate of treatment success, chemotherapy has been used in the past for young children because of fear among physicians and parents of radiation-related treatment effects.

Merchant is the principal investigator and lead author of the JCO report.

"The long-term problems with cognitive development caused by traditional radiation therapy make this treatment unpopular among both physicians and parents," Merchant said. "However, the improved outcomes we have seen in both disease control and intellectual development using CRT suggest that it might be possible to reintroduce the routine use of radiation therapy as a treatment option even for very young children."

Merchant is currently principal investigator for a national trial of CRT for ependymoma based on the study’s findings. The trial is conducted by the Children’s Oncology Group.

CRT combines CAT scans and MRI to create pictures of the cancer that a computer then turns into three-dimensional images of the tumor exactly as it appears in the brain. These images are combined with computer-controlled radiation beams and meticulous positioning of the treatment table on which the patient lies. Radiation hits the tumor at precisely calculated angles and depths matching the 3-D image of the tumor, obliterating the cancer and sparing healthy tissue.

The median age of the 88 patients in the St. Jude study was 2.85 years, and 48 patients were younger than three years. According to Merchant, the inclusion of children younger than 3 years at the time of irradiation was unique, since children in this age group are at greatest risk of the effects of irradiation.

Before CRT, all patients underwent surgery to remove as much tumor as possible. Patients underwent testing of their cognitive abilities before CRT and again at six, 12, 24, 36, 48 and 60 months after start of radiation therapy. The tests varied according to age and included assessments of IQ, verbal memory and recall, academic achievement and other developmental skills that could be disrupted by radiation damage to the brain.

Merchant attributes the encouraging results of the study to three factors: 1) the large number of patients that underwent extensive surgery to remove most of the tumor before irradiation therapy; 2) the use of CRT to target tumors; and 3) the relatively high dose of radiation that could be used with CRT without jeopardizing healthy brain tissue.

Bonnie Cameron | EurekAlert!
Further information:
http://www.stjude.org

More articles from Health and Medicine:

nachricht Cystic fibrosis alters the structure of mucus in airways
28.06.2017 | University of Iowa Health Care

nachricht Mice provide insight into genetics of autism spectrum disorders
28.06.2017 | University of California - Davis

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Supersensitive through quantum entanglement

28.06.2017 | Physics and Astronomy

X-ray photoelectron spectroscopy under real ambient pressure conditions

28.06.2017 | Physics and Astronomy

Mice provide insight into genetics of autism spectrum disorders

28.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>